IGF2R and laryngeal carcinoma: Finally, the role of IGF2R in laryngeal cancer remains to be elucidated [33], although it appears probable that the lack of a tyrosine kinase domain deprives the receptor from the ability to transduce proliferative signals and may thus explain the absence of prognostic value of the marker observed in our cohort.